Clinical Trial Update: Investigation of Efficacy and Safety of EPOGAM [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of EPOGAM has completed, studying its use in atopic dermatitis and neurodermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Neurodermatitis

Drugs mentioned

• EPOGAM

Snippet

Sponsor: Max Zeller Soehne AG | Conditions: Atopic Dermatitis, Neurodermatitis | Phase 4 | Status: COMPLETED